This follows the expected launching of Kenya National School-Based Deworming (NSBD) next week across the country, targeting six million learners aged between 2-14 years in both public and private schools and out of school children within this age bracket.
The 2024 deworming medicines have been donated through the support of Evidence Action procuring 6,134,000 Albendazole tablets and 198,000 Praziquantel tablets.
Evidence Action has been a partner of Kenya’s Ministry of Health and Ministry of Education, alongside other partners such as the CIFF, The End Fund, GiveWell and the World Health Organization for the purposes of establishing, scaling, and maintaining the Kenya National School-Based Deworming Programme.